Mary Caffrey

The findings are consistent with other results that have shown sizable drops in A1C, as well as the ability to control blood pressure in patients who previously failed to meet targets.

The report highlights insights from experts at the recent meeting, Patient-Centered Diabetes Care. Failing to treat obesity will only cost more later, experts said.

Officials are using innovative methods like automatically enrolling beneficiaries based on their eligibility for foods stamps, and adding a large group that takes part in an existing New Orleans-area health project but currently lacks prescription drug coverage.

As CDC reports a record number of deaths from hepatitis C, it seeks to raise awareness of the need for screening and treatment. Authors and the editor of a special issue of The American Journal of Managed Care will take part in a briefing on the issue.

While final decisions will come in Septembers, Aetna's early word comes in contrast with that of other large insurers heading into 2017.

Five states report that 1 in 3 adults meet the CDC definition of obesity, which is having a body mass index of 30 or more.

While health plans and PBMs have taken a variety of approaches to control spending on the new class of cholesterol fighting drugs, Cigna is the first to reach value-based agreements with the drug makers.

Exclusivity deals in managed care to hold down the cost of drug therapy are not new. But requiring persons with type 1 diabetes to use insulin pumps from a single manufacturer has brought out a whole different reaction.

Experiments with mice suggest a potential early treatment to avoid a deadly infection.

FDA's requirement for large, cardiovascular safety trials for all new diabetes and obesity drugs has created a "cottage industry" that some see as necessary but others feel drives up drug costs.

The matchstick-like device is placed under the skin and continuously delivers exenatide to ovecome a chief hurdle in diabetes care: poor adherence.

Six years after the adoption of the Affordable Care Act, a physicians' group says corporate interests are pushing aside the concerns of doctors and the needs of patients.

Even though prices for both drugs in Britain was less than half the list price in the United States, NICE demanded further discounts before issuing a draft guidance that the therapies were appropriate for those who cannot otherwise lower cholesterol.

Smoking rates reported by insurers serving the ACA exchanges were consistently lower than findings from the CDC, suggesting that some are not being honest to avoid surcharges.

Discovery of the mechanism that connects low testosterone with diabetes could lead to better treatments for men as they age.

CDC also published a separate study that found more people in the United States now die from hepatitis C than die from HIV or any other infectious disease. The report comes as The American Journal of Managed Care publishes a special issue on policy concerns over patient access to new therapies that cure HCV.

The method allows anti-obesity medication to reach fat tissue without causing side effects elsewhere in the body. So far, the method has been tested on mice.

The poll found most Americans remain unaware of federal parity laws on access to mental health care, 2 years into the implementation of the Affordable Care Act.

The crisis in Flint appears to have undermined public confidence in government's ability to deliver safe services, but Americans still trust state officials more than the federal government.

The study highlights the complexity of prescribing medication for those with type 2 diabetes.

This sweeping proposal is the biggest step yet in shifting reimbursement from a volume-based to a value-based system. Stakeholders offered mixed opinions this week.

Unlike its closest rival, CVS Health, Express Scripts does not have a retail healthcare delivery infrastructure.

One leading expert called the proposal the most substantive change in decades, but some feared CMS is once again hastening the demise of the independent physician.

Two years after CDC heralded a drop in obesity rates among the youngest children, authors of a new study say it's too soon to declare victory.

The study team previously published research that linked diabetes to elevated rates of certain cancers.

The FDA issued a warning on the SGLT2 inhibitor class in May 2015, but the review by AACE and ACE found that several of the cases involved patients with type 1 disease.

The rule creates the first public reporting system of quality for Medicaid managed care plans.

Policy solutions were grouped around the themes of transparency, competition, and value. Healthcare heavyweights like Kaiser Permanente, AARP, and the American Hospital Association have signed on to the cause.

The state's first-in-the-nation waiver to Medicaid seemed endangered in late 2014, but Governor Asa Hutchinson decided keeping people insured was worth it.

The study showed the need to test children with type 1 disease for a lack of vitamin D.